EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (3 days ago)
Profit from the extended deadline (May 31) for early-bird rates for the #eChemInfo Training and Innovation Course i… https://t.co/DrnKO5j0O4
Douglas Connect (5 days ago)
RT @madAniceP: Continuation of #workshop to resolve your problems in #drugdesign. Excited to be a part of this event and looking forward to…
Douglas Connect (2 weeks ago)
OpenTox Asia 2018 begins next week! Join us in Tokyo to discuss systems toxicology and how we form a foundation for… https://t.co/i5beiwDCJE
Douglas Connect (3 weeks ago)
https://t.co/XlgYyhQD70
Douglas Connect (4 weeks ago)
@CRACK_IT Douglas Connect's latest App pulls 3Rs (Replacement, Reduction and Refinement of animal testing) knowledg… https://t.co/CoDH16tC5d

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com